Mazdutide and survodutide are synthetic peptides studied for dual activity at glucagon-like peptide-1 (GLP-1) and glucagon receptors. Despite sharing these receptor targets, they are chemically distinct compounds.
For laboratories comparing Mazdutide vs Survodutide, the most important purchasing considerations are molecular identity, peptide modifications, receptor assay evidence and batch-specific documentation.
Mazdutide vs Survodutide: Scientific Differences
Mazdutide, also known as IBI362 or LY3305677, is an oxyntomodulin analogue developed for dual GLP-1/glucagon receptor agonism.
Survodutide, also called BI 456906, is another modified dual-receptor peptide agonist studied in metabolic and liver-related research.
Their molecular designs and pharmacological profiles differ. Results obtained with one compound cannot automatically be applied to the other.
| Product specification | Mazdutide | Survodutide |
|---|---|---|
| Development identifier | IBI362 / LY3305677 | BI 456906 |
| Peptide class | Oxyntomodulin analogue | Modified dual-receptor agonist |
| Receptor targets | GLP-1 and glucagon | GLP-1 and glucagon |
| Molecular identity | Compound-specific sequence and modifications | Distinct sequence and modifications |
| Functional assessment | GLP-1/glucagon receptor assays | GLP-1/glucagon receptor assays |
| Procurement requirement | Batch-matched identity evidence | Batch-matched identity evidence |
Five Product Specifications Buyers Should Verify
1. Peptide Sequence and Molecular Mass
Request the complete molecular identity, expected mass and structural modifications.
The description “GLP-1/glucagon dual agonist” cannot establish whether a vial contains mazdutide or survodutide.
2. Receptor Activity Documentation
Where receptor pharmacology matters, request functional data for both receptor systems.
Compare assay methods, reference compounds and reported potency values. Results from different assay conditions may not be directly comparable.
3. Peptide Content and Purity
HPLC can assess chromatographic purity, while mass spectrometry supports molecular identity.
Buyers should also distinguish actual peptide content from total powder mass, which may include counterions, moisture or excipients.
4. Powder and Solution Formats
Lyophilised products require declared content, excipients and supported storage information.
Prepared solutions additionally require concentration, fill volume, solvent composition and formulation-specific stability evidence.
Neither compound should be assigned storage conditions solely because another dual agonist uses them.
5. Certificate of Analysis
Request a COA identifying the exact compound, batch number, test methods and analytical results.
A generic certificate covering several dual agonists is not adequate evidence for a specific batch.
For further procurement guidance, see our mazdutide identity verification guide and survodutide versus cotadutide comparison.
Frequently Asked Questions
1. Are mazdutide and survodutide identical?
No. They are distinct synthetic peptides.
2. Is mazdutide an oxyntomodulin analogue?
Yes.
3. Does survodutide target glucagon receptors?
Yes, alongside GLP-1 receptors.
4. Does equal purity mean equal potency?
No. Potency requires appropriate functional assays.
5. Can both compounds be supplied as powders?
Powder formulations may be offered, but individual listings require verification.
6. Should both have batch-specific COAs?
Yes. Batch-matched documentation supports traceability.
Conclusion
The main distinction in Mazdutide vs Survodutide lies in molecular design and compound-specific pharmacology. UK laboratories should verify identity, analytical quality, formulation and supporting documentation independently.
For laboratory research only. Not intended for human administration or clinical use.
Scientific and Technical References
- PubMed — Mazdutide research: https://pubmed.ncbi.nlm.nih.gov/?term=mazdutide
- PubMed — Survodutide research: https://pubmed.ncbi.nlm.nih.gov/?term=survodutide
- ICH Q2(R2) — Validation of Analytical Procedures: https://www.ich.org/page/quality-guidelines
These sources provide scientific context rather than verification of individual supplier products.